Global Gastrointestinal Cancer Treatment Market Insights and Forecast to 2028

Report ID: 1802546 | Published Date: Jan 2025 | No. of Page: 116 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Surgery
        1.2.3 Targeted Drugs Therapy
        1.2.4 Chemo Therapy
        1.2.5 Adjuvant Chemotherapy
        1.2.6 Radiation Therapy
    1.3 Market by Application
        1.3.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Research Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2017-2028)
    2.2 Gastrointestinal Cancer Treatment Growth Trends by Region
        2.2.1 Gastrointestinal Cancer Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gastrointestinal Cancer Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Gastrointestinal Cancer Treatment Market Dynamics
        2.3.1 Gastrointestinal Cancer Treatment Industry Trends
        2.3.2 Gastrointestinal Cancer Treatment Market Drivers
        2.3.3 Gastrointestinal Cancer Treatment Market Challenges
        2.3.4 Gastrointestinal Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue
        3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2017-2022)
        3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue
    3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio
        3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2021
    3.5 Gastrointestinal Cancer Treatment Key Players Head office and Area Served
    3.6 Key Players Gastrointestinal Cancer Treatment Product Solution and Service
    3.7 Date of Enter into Gastrointestinal Cancer Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Cancer Treatment Breakdown Data by Type
    4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2023-2028)
5 Gastrointestinal Cancer Treatment Breakdown Data by Application
    5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gastrointestinal Cancer Treatment Market Size (2017-2028)
    6.2 North America Gastrointestinal Cancer Treatment Market Size by Type
        6.2.1 North America Gastrointestinal Cancer Treatment Market Size by Type (2017-2022)
        6.2.2 North America Gastrointestinal Cancer Treatment Market Size by Type (2023-2028)
        6.2.3 North America Gastrointestinal Cancer Treatment Market Share by Type (2017-2028)
    6.3 North America Gastrointestinal Cancer Treatment Market Size by Application
        6.3.1 North America Gastrointestinal Cancer Treatment Market Size by Application (2017-2022)
        6.3.2 North America Gastrointestinal Cancer Treatment Market Size by Application (2023-2028)
        6.3.3 North America Gastrointestinal Cancer Treatment Market Share by Application (2017-2028)
    6.4 North America Gastrointestinal Cancer Treatment Market Size by Country
        6.4.1 North America Gastrointestinal Cancer Treatment Market Size by Country (2017-2022)
        6.4.2 North America Gastrointestinal Cancer Treatment Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Gastrointestinal Cancer Treatment Market Size (2017-2028)
    7.2 Europe Gastrointestinal Cancer Treatment Market Size by Type
        7.2.1 Europe Gastrointestinal Cancer Treatment Market Size by Type (2017-2022)
        7.2.2 Europe Gastrointestinal Cancer Treatment Market Size by Type (2023-2028)
        7.2.3 Europe Gastrointestinal Cancer Treatment Market Share by Type (2017-2028)
    7.3 Europe Gastrointestinal Cancer Treatment Market Size by Application
        7.3.1 Europe Gastrointestinal Cancer Treatment Market Size by Application (2017-2022)
        7.3.2 Europe Gastrointestinal Cancer Treatment Market Size by Application (2023-2028)
        7.3.3 Europe Gastrointestinal Cancer Treatment Market Share by Application (2017-2028)
    7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country
        7.4.1 Europe Gastrointestinal Cancer Treatment Market Size by Country (2017-2022)
        7.4.2 Europe Gastrointestinal Cancer Treatment Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type
        8.2.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Type (2017-2028)
    8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application
        8.3.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Share by Application (2017-2028)
    8.4 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region
        8.4.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Gastrointestinal Cancer Treatment Market Size (2017-2028)
    9.2 Latin America Gastrointestinal Cancer Treatment Market Size by Type
        9.2.1 Latin America Gastrointestinal Cancer Treatment Market Size by Type (2017-2022)
        9.2.2 Latin America Gastrointestinal Cancer Treatment Market Size by Type (2023-2028)
        9.2.3 Latin America Gastrointestinal Cancer Treatment Market Share by Type (2017-2028)
    9.3 Latin America Gastrointestinal Cancer Treatment Market Size by Application
        9.3.1 Latin America Gastrointestinal Cancer Treatment Market Size by Application (2017-2022)
        9.3.2 Latin America Gastrointestinal Cancer Treatment Market Size by Application (2023-2028)
        9.3.3 Latin America Gastrointestinal Cancer Treatment Market Share by Application (2017-2028)
    9.4 Latin America Gastrointestinal Cancer Treatment Market Size by Country
        9.4.1 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2017-2022)
        9.4.2 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type
        10.2.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Type (2017-2028)
    10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application
        10.3.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Share by Application (2017-2028)
    10.4 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country
        10.4.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction
        11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.1.5 Eli Lilly Recent Developments
    11.2 F. Hoffmann
        11.2.1 F. Hoffmann Company Details
        11.2.2 F. Hoffmann Business Overview
        11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction
        11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.2.5 F. Hoffmann Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction
        11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Gastrointestinal Cancer Treatment Introduction
        11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.4.5 Merck Recent Developments
    11.5 Novartis AG
        11.5.1 Novartis AG Company Details
        11.5.2 Novartis AG Business Overview
        11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction
        11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.5.5 Novartis AG Recent Developments
    11.6 Otsuka Holdings
        11.6.1 Otsuka Holdings Company Details
        11.6.2 Otsuka Holdings Business Overview
        11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction
        11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.6.5 Otsuka Holdings Recent Developments
    11.7 Stryker Corporation
        11.7.1 Stryker Corporation Company Details
        11.7.2 Stryker Corporation Business Overview
        11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction
        11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.7.5 Stryker Corporation Recent Developments
    11.8 Boston Scientific Corporation
        11.8.1 Boston Scientific Corporation Company Details
        11.8.2 Boston Scientific Corporation Business Overview
        11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction
        11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.8.5 Boston Scientific Corporation Recent Developments
    11.9 Johnson and Johnson
        11.9.1 Johnson and Johnson Company Details
        11.9.2 Johnson and Johnson Business Overview
        11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction
        11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.9.5 Johnson and Johnson Recent Developments
    11.10 CONMED Corporation
        11.10.1 CONMED Corporation Company Details
        11.10.2 CONMED Corporation Business Overview
        11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction
        11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.10.5 CONMED Corporation Recent Developments
    11.11 Bristol-Myers Squibb
        11.11.1 Bristol-Myers Squibb Company Details
        11.11.2 Bristol-Myers Squibb Business Overview
        11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction
        11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.11.5 Bristol-Myers Squibb Recent Developments
    11.12 Pfizer
        11.12.1 Pfizer Company Details
        11.12.2 Pfizer Business Overview
        11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction
        11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.12.5 Pfizer Recent Developments
    11.13 Celltrion Inc
        11.13.1 Celltrion Inc Company Details
        11.13.2 Celltrion Inc Business Overview
        11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction
        11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.13.5 Celltrion Inc Recent Developments
    11.14 Amgen Limited
        11.14.1 Amgen Limited Company Details
        11.14.2 Amgen Limited Business Overview
        11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction
        11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.14.5 Amgen Limited Recent Developments
    11.15 Celgene Corporation
        11.15.1 Celgene Corporation Company Details
        11.15.2 Celgene Corporation Business Overview
        11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction
        11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.15.5 Celgene Corporation Recent Developments
    11.16 Sanofi
        11.16.1 Sanofi Company Details
        11.16.2 Sanofi Business Overview
        11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction
        11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2017-2022)
        11.16.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Surgery
    Table 3. Key Players of Targeted Drugs Therapy
    Table 4. Key Players of Chemo Therapy
    Table 5. Key Players of Adjuvant Chemotherapy
    Table 6. Key Players of Radiation Therapy
    Table 7. Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Gastrointestinal Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Gastrointestinal Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Gastrointestinal Cancer Treatment Market Share by Region (2017-2022)
    Table 11. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Gastrointestinal Cancer Treatment Market Share by Region (2023-2028)
    Table 13. Gastrointestinal Cancer Treatment Market Trends
    Table 14. Gastrointestinal Cancer Treatment Market Drivers
    Table 15. Gastrointestinal Cancer Treatment Market Challenges
    Table 16. Gastrointestinal Cancer Treatment Market Restraints
    Table 17. Global Gastrointestinal Cancer Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Gastrointestinal Cancer Treatment Revenue Share by Players (2017-2022)
    Table 19. Global Top Gastrointestinal Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2021)
    Table 20. Ranking of Global Top Gastrointestinal Cancer Treatment Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Gastrointestinal Cancer Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Gastrointestinal Cancer Treatment Product Solution and Service
    Table 24. Date of Enter into Gastrointestinal Cancer Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2017-2022)
    Table 28. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Gastrointestinal Cancer Treatment Revenue Market Share by Type (2023-2028)
    Table 30. Global Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Gastrointestinal Cancer Treatment Revenue Share by Application (2017-2022)
    Table 32. Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Gastrointestinal Cancer Treatment Revenue Share by Application (2023-2028)
    Table 34. North America Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Gastrointestinal Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Gastrointestinal Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Gastrointestinal Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Gastrointestinal Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Gastrointestinal Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Gastrointestinal Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Gastrointestinal Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Gastrointestinal Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Gastrointestinal Cancer Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Gastrointestinal Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Gastrointestinal Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Gastrointestinal Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Gastrointestinal Cancer Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Eli Lilly Company Details
    Table 65. Eli Lilly Business Overview
    Table 66. Eli Lilly Gastrointestinal Cancer Treatment Product
    Table 67. Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 68. Eli Lilly Recent Developments
    Table 69. F. Hoffmann Company Details
    Table 70. F. Hoffmann Business Overview
    Table 71. F. Hoffmann Gastrointestinal Cancer Treatment Product
    Table 72. F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 73. F. Hoffmann Recent Developments
    Table 74. GlaxoSmithKline Company Details
    Table 75. GlaxoSmithKline Business Overview
    Table 76. GlaxoSmithKline Gastrointestinal Cancer Treatment Product
    Table 77. GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 78. GlaxoSmithKline Recent Developments
    Table 79. Merck Company Details
    Table 80. Merck Business Overview
    Table 81. Merck Gastrointestinal Cancer Treatment Product
    Table 82. Merck Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 83. Merck Recent Developments
    Table 84. Novartis AG Company Details
    Table 85. Novartis AG Business Overview
    Table 86. Novartis AG Gastrointestinal Cancer Treatment Product
    Table 87. Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 88. Novartis AG Recent Developments
    Table 89. Otsuka Holdings Company Details
    Table 90. Otsuka Holdings Business Overview
    Table 91. Otsuka Holdings Gastrointestinal Cancer Treatment Product
    Table 92. Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 93. Otsuka Holdings Recent Developments
    Table 94. Stryker Corporation Company Details
    Table 95. Stryker Corporation Business Overview
    Table 96. Stryker Corporation Gastrointestinal Cancer Treatment Product
    Table 97. Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 98. Stryker Corporation Recent Developments
    Table 99. Boston Scientific Corporation Company Details
    Table 100. Boston Scientific Corporation Business Overview
    Table 101. Boston Scientific Corporation Gastrointestinal Cancer Treatment Product
    Table 102. Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 103. Boston Scientific Corporation Recent Developments
    Table 104. Johnson and Johnson Company Details
    Table 105. Johnson and Johnson Business Overview
    Table 106. Johnson and Johnson Gastrointestinal Cancer Treatment Product
    Table 107. Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 108. Johnson and Johnson Recent Developments
    Table 109. CONMED Corporation Company Details
    Table 110. CONMED Corporation Business Overview
    Table 111. CONMED Corporation Gastrointestinal Cancer Treatment Product
    Table 112. CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 113. CONMED Corporation Recent Developments
    Table 114. Bristol-Myers Squibb Company Details
    Table 115. Bristol-Myers Squibb Business Overview
    Table 116. Bristol-Myers Squibb Gastrointestinal Cancer Treatment Product
    Table 117. Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 118. Bristol-Myers Squibb Recent Developments
    Table 119. Pfizer Company Details
    Table 120. Pfizer Business Overview
    Table 121. Pfizer Gastrointestinal Cancer Treatment Product
    Table 122. Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 123. Pfizer Recent Developments
    Table 124. Celltrion Inc Company Details
    Table 125. Celltrion Inc Business Overview
    Table 126. Celltrion Inc Gastrointestinal Cancer Treatment Product
    Table 127. Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 128. Celltrion Inc Recent Developments
    Table 129. Amgen Limited Company Details
    Table 130. Amgen Limited Business Overview
    Table 131. Amgen Limited Gastrointestinal Cancer Treatment Product
    Table 132. Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 133. Amgen Limited Recent Developments
    Table 134. Celgene Corporation Company Details
    Table 135. Celgene Corporation Business Overview
    Table 136. Celgene Corporation Gastrointestinal Cancer Treatment Product
    Table 137. Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 138. Celgene Corporation Recent Developments
    Table 139. Sanofi Company Details
    Table 140. Sanofi Business Overview
    Table 141. Sanofi Gastrointestinal Cancer Treatment Product
    Table 142. Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 143. Sanofi Recent Developments
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gastrointestinal Cancer Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Surgery Features
    Figure 3. Targeted Drugs Therapy Features
    Figure 4. Chemo Therapy Features
    Figure 5. Adjuvant Chemotherapy Features
    Figure 6. Radiation Therapy Features
    Figure 7. Global Gastrointestinal Cancer Treatment Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Research Centers Case Studies
    Figure 11. Others Case Studies
    Figure 12. Gastrointestinal Cancer Treatment Report Years Considered
    Figure 13. Global Gastrointestinal Cancer Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Gastrointestinal Cancer Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Gastrointestinal Cancer Treatment Market Share by Region: 2021 VS 2028
    Figure 16. Global Gastrointestinal Cancer Treatment Market Share by Players in 2021
    Figure 17. Global Top Gastrointestinal Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Cancer Treatment as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Gastrointestinal Cancer Treatment Revenue in 2021
    Figure 19. North America Gastrointestinal Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Gastrointestinal Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 21. North America Gastrointestinal Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 22. North America Gastrointestinal Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 23. United States Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Gastrointestinal Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Gastrointestinal Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Gastrointestinal Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Gastrointestinal Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 29. Germany Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Gastrointestinal Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Gastrointestinal Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Gastrointestinal Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Gastrointestinal Cancer Treatment Market Size Share by Region (2017-2028)
    Figure 39. China Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Gastrointestinal Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Gastrointestinal Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Gastrointestinal Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Gastrointestinal Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 49. Mexico Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Gastrointestinal Cancer Treatment Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Gastrointestinal Cancer Treatment Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Gastrointestinal Cancer Treatment Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Gastrointestinal Cancer Treatment Market Size Share by Country (2017-2028)
    Figure 55. Turkey Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Gastrointestinal Cancer Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Eli Lilly Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 59. F. Hoffmann Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 61. Merck Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 62. Novartis AG Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 63. Otsuka Holdings Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 64. Stryker Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 65. Boston Scientific Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 66. Johnson and Johnson Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 67. CONMED Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 68. Bristol-Myers Squibb Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 69. Pfizer Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 70. Celltrion Inc Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 71. Amgen Limited Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 72. Celgene Corporation Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 73. Sanofi Revenue Growth Rate in Gastrointestinal Cancer Treatment Business (2017-2022)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
F. Hoffmann
GlaxoSmithKline
Merck
Novartis AG
Otsuka Holdings
Stryker Corporation
Boston Scientific Corporation
Johnson and Johnson
CONMED Corporation
Bristol-Myers Squibb
Pfizer
Celltrion Inc
Amgen Limited
Celgene Corporation
Sanofi
Frequently Asked Questions
Gastrointestinal Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastrointestinal Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastrointestinal Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hemicellulase

Hemicellulase market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More